Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
p53 expression as a prognostic marker in inflammatory breast cancer.
Gonzalez-Angulo AM, Sneige N, Buzdar AU, Valero V, Kau SW, Broglio K, Yamamura Y, Hortobagyi GN, Cristofanilli M. Gonzalez-Angulo AM, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6215-21. doi: 10.1158/1078-0432.CCR-04-0202. Clin Cancer Res. 2004. PMID: 15448010
Adjuvant systemic therapy for male breast carcinoma.
Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Cancer. 2005 Dec 1;104(11):2359-64. doi: 10.1002/cncr.21526. Cancer. 2005. PMID: 16270318 Free article.
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy.
Hennessy BT, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M, Kau SW, Broglio K, Fornage B, Singletary SE, Sahin A, Buzdar AU, Valero V. Hennessy BT, et al. Cancer. 2006 Mar 1;106(5):1000-6. doi: 10.1002/cncr.21726. Cancer. 2006. PMID: 16444747 Free article. Clinical Trial.
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach.
Cristofanilli M, Krishnamurthy S, Guerra L, Broglio K, Arun B, Booser DJ, Menander K, Van Wart Hood J, Valero V, Hortobagyi GN. Cristofanilli M, et al. Cancer. 2006 Sep 1;107(5):935-44. doi: 10.1002/cncr.22080. Cancer. 2006. PMID: 16874816 Free article. Clinical Trial.
119 results